Mitral regurgitation epidemiology and demographics: Difference between revisions
Gerald Chi (talk | contribs) No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The incidence of mitral regurgitation is approximately 2% in a modern Western population. In the past, rheumatic heart disease was the leading cause of mitral regurgitation in Western countries, but now [[mitral valve prolapse]] is the leading cause and accounts for 45% of cases in Western countries. In Asia, North Africa, and the Middle East, and among some immagrant populations in the US, rheumatic heart disease remains the leading cause of mitral regurgitation. | The incidence of mitral regurgitation is approximately 2% in a modern Western population. In the past, rheumatic heart disease was the leading cause of mitral regurgitation in Western countries, but now [[mitral valve prolapse]] is the leading cause and accounts for 45% of cases in Western countries.<ref name='MedicineNetMVP-Kulick'>{{cite web|url=http://www.medicinenet.com/mitral_valve_prolapse/article.htm|title=Mitral Valve Prolapse (MVP) |accessdate=2010-01-18 |last=Kulick |first=Daniel|work=MedicineNet.com |publisher=MedicineNet, Inc }}</ref> In Asia, North Africa, and the Middle East, and among some immagrant populations in the US, rheumatic heart disease remains the leading cause of mitral regurgitation. | ||
==Age== | ==Age== | ||
Mitral regurgitation is one of the two most common valvular heart disease in the elderly, and is the most common form of valvular insufficiency <ref name=uptodate>[http://www.uptodate.com/patients/content/topic.do?topicKey=~PxxZxAzdJkaEgaZ Valvular heart disease in elderly adults] Authors: Dania Mohty, Maurice Enriquez-Sarano. Section Editors:Catherine M Otto, Kenneth E Schmader. Deputy Editor: Susan B Yeon. This topic last updated: April 20, 2007. Last literature review version 18.2: May 2010</ref> | Mitral regurgitation is one of the two most common valvular heart disease in the elderly, and is the most common form of valvular insufficiency.<ref name=uptodate>[http://www.uptodate.com/patients/content/topic.do?topicKey=~PxxZxAzdJkaEgaZ Valvular heart disease in elderly adults] Authors: Dania Mohty, Maurice Enriquez-Sarano. Section Editors:Catherine M Otto, Kenneth E Schmader. Deputy Editor: Susan B Yeon. This topic last updated: April 20, 2007. Last literature review version 18.2: May 2010</ref> Among patients over the age of 55, 20% will have mitral regurgitation. The most common cause in the developed world is [[mitral valve prolapse]] and in the developing world is [[rheumatic heart disease]]. The mean age of presentation in patients with [[rheumatic heart disease]] is 36 years. | ||
==Gender== | ==Gender== | ||
Overall, mitral regurgitation affects both males and females equally <ref>[http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/mitral-valve-disease/ The Cleveland Clinic Center for Continuing Education > Mitral Valve Disease: Stenosis and Regurgitation] Authors: Ronan J. Curtin and Brian P. Griffin. Retrieved September 2010</ref> | Overall, mitral regurgitation affects both males and females equally.<ref>[http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/mitral-valve-disease/ The Cleveland Clinic Center for Continuing Education > Mitral Valve Disease: Stenosis and Regurgitation] Authors: Ronan J. Curtin and Brian P. Griffin. Retrieved September 2010</ref> However, there are some minor imbalances when age is considered. In patients younger than 20 years, there is a male preponderance, and the severity of involvement is greater in males over the age of 50. [[ MVP]] is a common cause. However, most patients with MVP do not develop severe mitral regurgitation. Older age, male gender, and auscultatory evidence of severe MR are prognostic clues that identify patients with mitral valve prolapse who are at a relatively high risk of complications), myxomatous degeneration. | ||
==References== | ==References== | ||
Revision as of 15:55, 13 November 2013
 |
Resident Survival Guide |
| File:Critical Pathways.gif |
|
Mitral Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mitral regurgitation epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mitral regurgitation epidemiology and demographics |
|
Mitral regurgitation epidemiology and demographics in the news |
|
Risk calculators and risk factors for Mitral regurgitation epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
Overview
Epidemiology and Demographics
The incidence of mitral regurgitation is approximately 2% in a modern Western population. In the past, rheumatic heart disease was the leading cause of mitral regurgitation in Western countries, but now mitral valve prolapse is the leading cause and accounts for 45% of cases in Western countries.[1] In Asia, North Africa, and the Middle East, and among some immagrant populations in the US, rheumatic heart disease remains the leading cause of mitral regurgitation.
Age
Mitral regurgitation is one of the two most common valvular heart disease in the elderly, and is the most common form of valvular insufficiency.[2] Among patients over the age of 55, 20% will have mitral regurgitation. The most common cause in the developed world is mitral valve prolapse and in the developing world is rheumatic heart disease. The mean age of presentation in patients with rheumatic heart disease is 36 years.
Gender
Overall, mitral regurgitation affects both males and females equally.[3] However, there are some minor imbalances when age is considered. In patients younger than 20 years, there is a male preponderance, and the severity of involvement is greater in males over the age of 50. MVP is a common cause. However, most patients with MVP do not develop severe mitral regurgitation. Older age, male gender, and auscultatory evidence of severe MR are prognostic clues that identify patients with mitral valve prolapse who are at a relatively high risk of complications), myxomatous degeneration.
References
- ↑ Kulick, Daniel. "Mitral Valve Prolapse (MVP)". MedicineNet.com. MedicineNet, Inc. Retrieved 2010-01-18.
- ↑ Valvular heart disease in elderly adults Authors: Dania Mohty, Maurice Enriquez-Sarano. Section Editors:Catherine M Otto, Kenneth E Schmader. Deputy Editor: Susan B Yeon. This topic last updated: April 20, 2007. Last literature review version 18.2: May 2010
- ↑ The Cleveland Clinic Center for Continuing Education > Mitral Valve Disease: Stenosis and Regurgitation Authors: Ronan J. Curtin and Brian P. Griffin. Retrieved September 2010